Phase 4 Bipolar Disorder Trial, Recruiting NCT06184581 Sponsor: University Hospital Bispebjerg and Frederiksberg Condition: Bipolar Disorder
Back to Bipolar Disorder

Phase 4 Bipolar Disorder Trial, Recruiting

NCT06184581
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Bipolar Disorder Type II, confirmed through a specific structured interview called a SCAN interview
  • You are between 18 and 70 years old
  • You are able to understand and give your own informed consent to take part in the trial

Who may not be able to join:

  • You have previously tried lamotrigine or lithium for more than 6 weeks at a proper dose and it either did not work for you or you could not tolerate it
  • You are currently taking mood-stabilising medications at the time of joining the trial
  • You have severe long-term kidney disease
  • You have severe heart failure
  • You have a heart condition called Brugada syndrome
  • You have severe underactive thyroid (hypothyroidism) that has not been brought under control even with treatment
  • You are currently pregnant, breastfeeding, or planning to become pregnant in the near future

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +45 38 64 70 81

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
University Hospital Bispebjerg and Frederiksberg
Registry
ClinicalTrials.gov
Start date
8 May 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Mood stabilization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov